{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:45:14Z","timestamp":1792446314757,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s13760-019-01160-0","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T05:02:21Z","timestamp":1559538141000},"page":"511-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical approach to neurodegenerative disorders in childhood: an updated overview"],"prefix":"10.1007","volume":"119","author":[{"given":"Mario","family":"Mastrangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-12-802395-2.00021-3","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG (2017) Concepts and classification of neurodegenerative diseases. Handb Clin Neurol 145:301\u2013307","journal-title":"Handb Clin Neurol"},{"key":"1160_CR2","first-page":"2","volume":"7","author":"MM Jan","year":"2002","unstructured":"Jan MM (2002) Clinical approach to children with suspected neurodegenerative disorders. Neurosciences (Riyadh) 7:2\u20136","journal-title":"Neurosciences (Riyadh)"},{"key":"1160_CR3","first-page":"130","volume":"24","author":"AT Waldman","year":"2018","unstructured":"Waldman AT (2018) Leukodystrophies. Continuum (Minneap Minn) 24:130\u2013149","journal-title":"Continuum (Minneap Minn)"},{"key":"1160_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/archdischild-2012-302840","volume":"98","author":"G Pierre","year":"2013","unstructured":"Pierre G (2013) Neurodegenerative disorders and metabolic disease. Arch Dis Child 98:618\u2013624","journal-title":"Arch Dis Child"},{"key":"1160_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","volume":"134","author":"MS van der Knaap","year":"2017","unstructured":"van der Knaap MS, Bugiani M (2017) Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol 134:351\u2013382","journal-title":"Acta Neuropathol"},{"key":"1160_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ymgme.2014.12.434","volume":"114","author":"S Parikh","year":"2015","unstructured":"Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A et al (2015) A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephalopathies. Mol Genet Metab 114:501\u2013515","journal-title":"Mol Genet Metab"},{"key":"1160_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1212\/WNL.0b013e3181eee46b","volume":"75","author":"JL Bonkowsky","year":"2010","unstructured":"Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R (2010) The burden of inherited leukodystrophies in children. Neurology 75:718\u2013725","journal-title":"Neurology"},{"key":"1160_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.12811","volume":"90","author":"A Charzewska","year":"2016","unstructured":"Charzewska A, Wierzba J, I\u017cycka-\u015awieszewska E, Bekiesi\u0144ska-Figatowska M, Jurek M, Gintowt A et al (2016) Hypomyelinating leukodystrophies\u2014a molecular insight into the white matter pathology. Clin Genet 90:293\u2013304","journal-title":"Clin Genet"},{"key":"1160_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12456","author":"P Zhou","year":"2018","unstructured":"Zhou P, He N, Zhang JW, Lin ZJ, Wang J, Yan LM et al (2018) Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies. Genes Brain Behav. \n                  https:\/\/doi.org\/10.1111\/gbb.12456","journal-title":"Genes Brain Behav"},{"key":"1160_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-3-319-57193-5_11","volume":"15","author":"I Helbig","year":"2017","unstructured":"Helbig I, von Deimling M, Marsh ED (2017) Epileptic encephalopathies as neurodegenerative disorders. Adv Neurobiol 15:295\u2013315","journal-title":"Adv Neurobiol"},{"key":"1160_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L et al (2017) ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 58:512\u2013521","journal-title":"Epilepsia"},{"key":"1160_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/humu.23149","volume":"38","author":"E Parrini","year":"2017","unstructured":"Parrini E, Marini C, Mei D, Galuppi A, Cellini E, Pucatti D et al (2017) Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum Mutat 38:216\u2013222","journal-title":"Hum Mutat"},{"key":"1160_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13760-016-0709-z","volume":"117","author":"S Gokben","year":"2017","unstructured":"Gokben S, Onay H, Yilmaz S, Atik T, Serdaroglu G, Tekin H et al (2017) Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy. Acta Neurol Belg 117:131\u2013138","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"1160_CR14","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","volume":"1832","author":"A Schulz","year":"2013","unstructured":"Schulz A, Kohlsch\u00fctter A, Mink J, Simonati A, Williams R (2013) NCL diseases\u2014clinical perspectives. Biochim Biophys Acta 1832(11):1801\u20131806","journal-title":"Biochim Biophys Acta"},{"key":"1160_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP et al (2018) International Niemann-Pick Disease Registry (INPDR). Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet J Rare Dis 13:50","journal-title":"Orphanet J Rare Dis"},{"key":"1160_CR16","first-page":"13","volume":"15","author":"J Cao","year":"2018","unstructured":"Cao J, Wu H, Li Z (2018) Recent perspectives of pediatric mitochondrial diseases. Exp Ther Med 15:13\u201318","journal-title":"Exp Ther Med"},{"key":"1160_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/jhg.2016.163","volume":"62","author":"T Mizuguchi","year":"2017","unstructured":"Mizuguchi T, Nakashima M, Kato M, Yamada K, Okanishi T, Ekhilevitch N et al (2017) PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder. J Hum Genet 62:525\u2013529","journal-title":"J Hum Genet"},{"key":"1160_CR18","doi-asserted-by":"crossref","unstructured":"Flor-de-Lima F, Sampaio M, Nahavandi N, Fernandes S, Le\u00e3o M (2014) Alsin related disorders: literature review and case study with novel mutations. Case Rep Genet 691515","DOI":"10.1155\/2014\/691515"},{"key":"1160_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","volume":"16","author":"PVS de Souza","year":"2017","unstructured":"de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB (2017) Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum 16:525\u2013551","journal-title":"Cerebellum"},{"key":"1160_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","volume":"261","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol 261:518\u2013539","journal-title":"Exp Neurol"},{"key":"1160_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ejpn.2018.01.008","volume":"22","author":"I Di Meo","year":"2018","unstructured":"Di Meo I, Tiranti V (2018) Classification and molecular pathogenesis of NBIA syndromes. Eur J Paediatr Neurol 22:272\u2013284","journal-title":"Eur J Paediatr Neurol"},{"key":"1160_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1590\/0004-282X20160080","volume":"74","author":"RP Salom\u00e3o","year":"2016","unstructured":"Salom\u00e3o RP, Pedroso JL, Gama MT, Dutra LA, Maciel RH, Godeiro-Junior C et al (2016) A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging. Arq Neuropsiquiatr 74:587\u2013596","journal-title":"Arq Neuropsiquiatr"},{"key":"1160_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.spen.2018.02.001","volume":"25","author":"A Inge","year":"2018","unstructured":"Inge A (2018) Meijer and Toni Pearson, the twists of pediatric dystonia: phenomenology, classification, and genetics. Semin Pediatr Neurol 25:65\u201374","journal-title":"Semin Pediatr Neurol"},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/WCO.0000000000000116","volume":"27","author":"SD Kim","year":"2014","unstructured":"Kim SD, Fung VS (2014) An update on Huntington\u2019s disease: from the gene to the clinic. Curr Opin Neurol 27:477\u2013483","journal-title":"Curr Opin Neurol"},{"issue":"17","key":"1160_CR25","first-page":"30591","volume":"S1769\u20137212","author":"K Peikert","year":"2017","unstructured":"Peikert K, Danek A, Hermann A (2017) Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome. Eur J Med Genet S1769\u20137212(17):30591\u201330598","journal-title":"Eur J Med Genet"},{"key":"1160_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10048-013-0355-z","volume":"14","author":"D Lal","year":"2013","unstructured":"Lal D, Becker K, Motameny S, Altm\u00fcller J, Thiele H, N\u00fcrnberg P et al (2013) Homozygous missense mutation of NDUFV1 as the cause of\u00a0infantile bilateral striatal necrosis. Neurogenetics 14:85\u201387","journal-title":"Neurogenetics"},{"key":"1160_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jnnp-2012-304426","volume":"85","author":"F Baertling","year":"2014","unstructured":"Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJ et al (2014) A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 85:257\u2013265","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1160_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1750-1172-6-50","volume":"6","author":"Y Namavar","year":"2011","unstructured":"Namavar Y, Barth PG, Poll-The BT, Baas F (2011) Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis 6:50","journal-title":"Orphanet J Rare Dis"},{"key":"1160_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12041-018-0911-2","volume":"97","author":"SD Venkatesh","year":"2018","unstructured":"Venkatesh SD, Kandasamy M, Moily NS, Vaidyanathan R, Kota LN, Adhikarla S et al (2018) Genetic testing for clinically suspected spinocerebellar ataxias: report from a tertiary referral centre in India. J Genet 97:219\u2013224","journal-title":"J Genet"},{"key":"1160_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.spen.2014.04.004","volume":"21","author":"JB Bodensteiner","year":"2014","unstructured":"Bodensteiner JB (2014) Friedreich ataxia. Semin Pediatr Neurol 21:72","journal-title":"Semin Pediatr Neurol"},{"key":"1160_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/dmcn.13426","volume":"59","author":"WP Whitehouse","year":"2017","unstructured":"Whitehouse WP (2017) Multidisciplinary care of children and young people with ataxia-telangiectasia. Dev Med Child Neurol 59:670","journal-title":"Dev Med Child Neurol"},{"issue":"Pt 12","key":"1160_CR32","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1093\/brain\/awt283","volume":"136","author":"M Krieger","year":"2013","unstructured":"Krieger M, Roos A, Stendel C, Claeys KG, Sonmez FM, Baudis M et al (2013) SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain 136(Pt 12):3634\u20133644","journal-title":"Brain"},{"key":"1160_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M et al (2018) Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103\u2013115","journal-title":"Neuromuscul Disord"},{"issue":"Pt 9","key":"1160_CR34","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/brain\/awr184","volume":"134","author":"J Baets","year":"2011","unstructured":"Baets J, Deconinck T, De Vriendt E et al (2011) Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 134(Pt 9):2664\u20132676","journal-title":"Brain"},{"issue":"5","key":"1160_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jfo.2017.11.017","volume":"41","author":"C Orssaud","year":"2018","unstructured":"Orssaud C, Robert MP, Bremond Gignac D (2018) Hereditary optic neuropathies in pediatric ophthalmology. J Fr Ophtalmol 41(5):402\u2013406","journal-title":"J Fr Ophtalmol"},{"key":"1160_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccm.2018.01.004","volume":"39","author":"JC Carter","year":"2018","unstructured":"Carter JC, Sheehan DW, Prochoroff A, Birnkrant DJ (2018) Muscular dystrophies. Clin Chest Med 39:377\u2013389","journal-title":"Clin Chest Med"},{"key":"1160_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1469-8749.2010.03717.x","volume":"52","author":"J Gutierrez","year":"2010","unstructured":"Gutierrez J, Issacson RS, Koppel BS (2010) Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol 52:901\u2013907","journal-title":"Dev Med Child Neurol"},{"key":"1160_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/B978-0-444-63849-6.00008-6","volume":"152","author":"JM Wilmshurst","year":"2018","unstructured":"Wilmshurst JM, Hammond CK, Donald K, Hoare J, Cohen K, Eley B (2018) NeuroAIDS in children. Handb Clin Neurol 152:99\u2013116","journal-title":"Handb Clin Neurol"},{"key":"1160_CR39","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple sclerosis. Lancet 391:1622\u20131636","journal-title":"Lancet"},{"key":"1160_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/B978-0-444-52891-9.00054-3","volume":"111","author":"T Granata","year":"2013","unstructured":"Granata T, Andermann F (2013) Rasmussen encephalitis. Handb Clin Neurol 111:511\u2013519","journal-title":"Handb Clin Neurol"},{"key":"1160_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.12.014","volume":"80","author":"E Berry-Kravis","year":"2018","unstructured":"Berry-Kravis E, Chin J, Hoffmann A, Winston A, Stoner R, LaGorio L et al (2018) Long-term treatment of Niemann-Pick type C1 disease with intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin. Pediatr Neurol 80:24\u201334","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1160_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jnc.14134","volume":"143","author":"S Maljevic","year":"2017","unstructured":"Maljevic S, Reid CA, Petrou S (2017) Models for discovery of targeted therapy in genetic epileptic encephalopathies. J Neurochem 143(1):30\u201348","journal-title":"J Neurochem"},{"key":"1160_CR43","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D et al (2018) CLN2 Study Group. Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med 378:1898\u20131907","journal-title":"N Engl J Med"},{"key":"1160_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-9-5","volume":"9","author":"L Chessa","year":"2014","unstructured":"Chessa L, Leuzzi V, Plebani A, Soresina A, Micheli R, D\u2019Agnano D et al (2014) Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia telangiectasia patients: results of a phase 2 trial. Orphanet J Rare Dis 9:5","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1160_CR45","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1212\/NXI.0000000000000098","volume":"2","author":"V Leuzzi","year":"2015","unstructured":"Leuzzi V, Micheli R, D\u2019Agnano D, Molinaro A, Venturi T, Plebani A et al (2015) Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia. Neurol Neuroimmunol Neuroinflamm 2(3):e98","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1160_CR46","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T et al (2013) Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158","journal-title":"Science"},{"key":"1160_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/0883073818792313","volume":"33","author":"E Gordon-Lipkin","year":"2018","unstructured":"Gordon-Lipkin E, Fatemi A (2018) Current therapeutic approaches in leukodystrophies: a review. J Child Neurol 33:861\u2013868","journal-title":"J Child Neurol"},{"key":"1160_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.omtm.2018.02.005","volume":"9","author":"RM Bailey","year":"2018","unstructured":"Bailey RM, Armao D, Nagabhushan Kalburgi S, Gray SJ (2018) Development of intrathecal AAV9 gene therapy for giant axonal neuropathy. Mol Ther Methods Clin Dev 9:160\u2013171","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"1160_CR49","first-page":"599","volume":"140","author":"E Georgiou","year":"2017","unstructured":"Georgiou E, Sidiropoulou K, Richter J, Papaneophytou C, Sargiannidou I, Kagiava A et al (2017) Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model. Brain 140(3):599\u2013616","journal-title":"Brain"},{"key":"1160_CR50","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J et al (2017) ENDEAR Study Group. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723\u20131732","journal-title":"N Engl J Med"},{"issue":"10101","key":"1160_CR51","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N et al (2017) Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390(10101):1489\u20131498","journal-title":"Lancet"},{"key":"1160_CR52","doi-asserted-by":"publisher","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","volume":"90","author":"JS Charleston","year":"2018","unstructured":"Charleston JS, Schnell FJ, Dworzak J, Donoghue C, Lewis S, Chen L et al (2018) Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production. Neurology 90:e2146\u2013e2154","journal-title":"Neurology"},{"issue":"1","key":"1160_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ana.25118","volume":"83","author":"TL Hagemann","year":"2018","unstructured":"Hagemann TL, Powers B, Mazur C, Kim A, Wheeler S, Hung G et al (2018) Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease. Ann Neurol 83(1):27\u201339","journal-title":"Ann Neurol"},{"key":"1160_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/nejmoa1900907","volume":"1","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA et al (2019) Targeting Huntingtin expression in patients with Huntington\u2019s Disease. N Engl J Med 1:1. \n                  https:\/\/doi.org\/10.1056\/nejmoa1900907","journal-title":"N Engl J Med"},{"key":"1160_CR55","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddy212","volume":"27","author":"MP Hughes","year":"2018","unstructured":"Hughes MP, Smith DA, Morris L, Fletcher C, Colaco A, Huebecker M et al (2018) AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathologyin a mouse model of Niemann-Pick type C1 disease. Hum Mol Genet 27:3079\u20133098","journal-title":"Hum Mol Genet"},{"key":"1160_CR56","first-page":"320","volume":"17","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Tian Z, Yuan J, Liu C, Liu HL, Ma SQ et al (2017) The progress of gene therapy for Leber\u2019s optic hereditary neuropathy. Curr Gene Ther 17:320\u2013326","journal-title":"Curr Gene Ther"}],"updated-by":[{"DOI":"10.1007\/s13760-019-01205-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000}}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-019-01160-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T14:34:17Z","timestamp":1604500457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-019-01160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1007\/s13760-019-01160-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13760-019-01205-4","asserted-by":"object"}]},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author regret that, in the section \ufffd\ufffd\ufffdDietary treatments\ufffd\ufffd\ufffd the sentence \ufffd\ufffd\ufffdKetogenic diet is the gold standard therapy for Glut 1 deficiency and pyruvate kinase deficiency but it can be also applied in severe drug-resistant epileptic encephalopathies [4].\ufffd\ufffd\ufffd is not correct.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no funding or conflict of interest to declare. This article does not contain any studies with human participants or animals performed by the author. The MRIs in Fig.\u00a0 were realized during an ordinary diagnostic workup of the involved patients and a parental informed consent for their publication was obtained for each one of them.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}